Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review

[1]  M. Bennett.  Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review , 2011, Palliative medicine.

[2]  E. Miranda,et al.  First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  P. Farquhar-smith.  Chemotherapy-induced neuropathic pain , 2011, Current opinion in supportive and palliative care.

[4]  Blair H. Smith,et al.  NeuPSIG guidelines on neuropathic pain assessment , 2011, PAIN®.

[5]  E. Bruera,et al.  An international multicentre validation study of a pain classification system for cancer patients. , 2010, European journal of cancer.

[6]  S. Khanna,et al.  Neuropathic pain in cancer patients--prevalence and management in a tertiary care anesthesia-run referral clinic based in urban India. , 2010, Journal of palliative medicine.

[7]  M. Bennett.  Cancer pain terminology: Time to develop a taxonomy that promotes good clinical practice and allows research to progress , 2010, PAIN.

[8]  F. De Conno,et al.  Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  S. Mercadante,et al.  Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. , 2009, The journal of pain : official journal of the American Pain Society.

[10]  P. S. Sillevis Smitt,et al.  A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. , 2009, European journal of cancer.

[11]  M. Hjermstad,et al.  Classification of pain in cancer patients – a systematic literature review , 2009, Palliative medicine.

[12]  A. Chatterjee,et al.  Prevalence, Etiology, and Management of Neuropathic Pain in an Indian Cancer Hospital , 2009, Journal of pain & palliative care pharmacotherapy.

[13]  S. Deandrea,et al.  Prevalence of undertreatment in cancer pain. A review of published literature. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Dagny Faksvåg Haugen,et al.  Symptom assessment in palliative care: a need for international collaboration. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[16]  H C Schouten,et al.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  M. Sanchez,et al.  250 PREVALENCE OF NEUROPATHIC PAIN IN CANCER PATIENTS , 2007 .

[18]  M. Bennett,et al.  Using screening tools to identify neuropathic pain , 2007, PAIN.

[19]  L. Vlahos,et al.  Comparison of pain quality descriptors in cancer patients with nociceptive and neuropathic pain. , 2007, In vivo.

[20]  M. Groenvold,et al.  Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care. , 2004, Journal of pain and symptom management.

[21]  I. Higginson,et al.  Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. , 2003, Journal of the Royal Society of Medicine.

[22]  I. Higginson,et al.  Cancer Pain: Cancer pain epidemiology: a systematic review , 2003 .

[23]  G. Gonzales,et al.  Neuropathic Pain in Patients with Cancer , 2003, Journal of palliative care.

[24]  I. Higginson,et al.  Cancer Pain : Assessment and Management , 2003 .

[25]  S. Kaasa,et al.  The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. , 2002, Journal of pain and symptom management.

[26]  K. Cain,et al.  Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. , 2001, Journal of pain and symptom management.

[27]  M. C. Lee,et al.  Pain and loss of function in head and neck cancer survivors. , 1999, Journal of pain and symptom management.

[28]  A. Caraceni,et al.  An international survey of cancer pain characteristics and syndromes , 1999, PAIN.

[29]  L. Radbruch,et al.  Assessment and treatment of neuropathic cancer pain following WHO guidelines , 1999, Pain.

[30]  J. Harcourt,et al.  A survey of pain in patients with advanced cancer. , 1996, Journal of pain and symptom management.

[31]  L. Radbruch,et al.  Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service , 1996, Pain.

[32]  S. Mercadante,et al.  Pain characteristics of advanced lung cancer patients referred to a palliative care service , 1994, Pain.

[33]  H. Thaler,et al.  Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms , 1994, Neurology.

[34]  A. Banning,et al.  Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic , 1991, Pain.

[35]  C. Vecht,et al.  Types and causes of pain in cancer of the head and neck , 1990, Pain.

[36]  R. Twycross,et al.  Pain in far-advanced cancer , 1982, Pain.